Odyssey Therapeutics Current Assets

Odyssey Therapeutics posts a current assets of $320M as of June 2026. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Current Assets is one piece of Odyssey Therapeutics's financial statement story. At $320M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ODTX's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Odyssey Therapeutics's other metric pages and overview cover the third.

Judging Odyssey Therapeutics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current assets easier to interpret. Start with $320M here, then scan peer and history charts to see if the gap is persistent.